Skip to main content
Year archive

SYNAIRGEN PLC — 2025 filings

All 14 regulatory filings released by SYNAIRGEN PLC (SNG) in 2025, sourced directly from the official regulator.

14 Filings
2025 Period
2025 filings (14)
Filing Released Lang
First Patient Dosed in the INVENT Clinical Study
Regulatory Filings
2025-12-08 English
Synairgen & Aerogen Announce Strategic Partnership
Regulatory Filings
2025-11-12 English
Publication of Annual Report and Accounts 2024
Report Publication Announcement
2025-09-30 English
Business Update
Regulatory Filings
2025-09-04 English
Board and Executive Leadership Changes
Board/Management Information
2025-05-16 English
Shares Admitted to Trading on Asset Match
Regulatory Filings
2025-05-08 English
John Bradshaw appointed as Non-Executive Director
Board/Management Information
2025-05-01 English
Update on trading post cancellation
Regulatory Filings
2025-04-03 English
Result of General Meeting
AGM Information
2025-03-28 English
Proposed cancellation of trading on AIM
Proxy Solicitation & Information Statement
2025-03-11 English
Holding(s) in Company
Major Shareholding Notification
2025-01-17 English
Martin Murphy appointed as Non-Executive Director
Board/Management Information
2025-01-16 English
Result of General Meeting and Total Voting Rights
AGM Information
2025-01-16 English
£18m raised to fund Phase 2 INVENT clinical trial
Share Issue/Capital Change
2025-01-15 English